Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.

[1]  T. Haferlach,et al.  Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing , 2018, Leukemia.

[2]  Travis M. Drucker,et al.  SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq). , 2018, Cancer genetics.

[3]  E. Clappier,et al.  The MLL recombinome of acute leukemias in 2017 , 2017, Leukemia.

[4]  Eunhee Kim,et al.  ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia , 2017, Nature Communications.

[5]  S. Miyano,et al.  ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1‐RUNX1T1 and associated with a better prognosis , 2017, Genes, chromosomes & cancer.

[6]  L. Bullinger,et al.  Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group , 2017, Leukemia.

[7]  F. He,et al.  Loss of Asxl2 leads to myeloid malignancies in mice , 2016, Nature Communications.

[8]  O. Abdel-Wahab,et al.  The Role of Additional Sex Combs-Like Proteins in Cancer. , 2016, Cold Spring Harbor perspectives in medicine.

[9]  B. Dörken,et al.  BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features , 2016, Annals of Hematology.

[10]  T. McDonnell,et al.  Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. , 2015, Blood.

[11]  Yali Dou,et al.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases , 2015, Nature Reviews Cancer.

[12]  O. Abdel-Wahab,et al.  Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. , 2014, Blood.

[13]  Travis M. Drucker,et al.  BIMA V3: an aligner customized for mate pair library sequencing , 2014, Bioinform..

[14]  C. Conley,et al.  Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation. , 2014, Cancer genetics.

[15]  K. Theil,et al.  The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors. , 2014, Cancer genetics.

[16]  A. Bagg,et al.  Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study , 2014, Haematologica.

[17]  J. D. Engel,et al.  A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. , 2014, Cancer cell.

[18]  W. Gorczyca.  Acute Myeloid Leukemia with Recurrent Genetic Abnormalities , 2014, Definitions.

[19]  O. Abdel-Wahab,et al.  Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations , 2014, Haematologica.

[20]  T. Haferlach,et al.  Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations , 2011, British journal of haematology.

[21]  R. Ketterling,et al.  Development of a dual‐color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia , 2010, American journal of hematology.

[22]  K. Theil,et al.  The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction. , 2006, Cancer genetics and cytogenetics.

[23]  A. Hagemeijer,et al.  The Philadelphia chromosome as a secondary abnormality in two cases of acute myeloid leukemia , 1998, British journal of haematology.

[24]  D. Hossfeld,et al.  Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies. , 1997, Cancer genetics and cytogenetics.

[25]  J. Bennett,et al.  B-Lymphoblastic Leukemia/Lymphoma , 2014 .